Evidence for multiple peroxisome proliferator-activated receptor γ transcripts in bone: Fine-tuning by hormonal regulation and mRNA stability

FEBS Letters

Volumn 582, Issue 11, 2008, Pages 1618-1624

  Bruedigam, Claudia ^a   Koedam, Marijke ^a   Chiba, Hideki ^b   Eijken, Marco ^a   van Leeuwen, Johannes P T M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b SAPPORO MEDICAL UNIVERSITY   (Japan)

Author keywords

Alternative splicing; Glucocorticoids; mRNA Stability; Osteoblast; Peroxisome proliferator activated receptor ; Rosiglitazone

Indexed keywords

DEXAMETHASONE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA 2; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA 3; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA 4;

ARTICLE; BONE DEVELOPMENT; CONTROLLED STUDY; GENE TARGETING; HORMONAL REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN STABILITY; RNA STABILITY; SIGNAL TRANSDUCTION; UPREGULATION;

ALTERNATIVE SPLICING; BONE AND BONES; CELL DIFFERENTIATION; CELL LINE; DEXAMETHASONE; GENE EXPRESSION REGULATION; HUMANS; OSTEOBLASTS; PPAR GAMMA; RNA STABILITY; RNA, MESSENGER; THIAZOLIDINEDIONES; TRANSCRIPTION, GENETIC;

EID: 42749083244     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2008.04.012     Document Type: Article

References (18)

1. Heikkinen S., Auwerx J., and Argmann C.A. PPARgamma in human and mouse physiology. Biochim. Biophys. Acta 1771 (2007) 8
2. Fajas L., Auboeuf D., Raspe E., Schoonjans K., Lefebvre A.M., Saladin R., Najib J., Laville M., Fruchart J.C., Deeb S., Vidal-Puig A., Flier J., Briggs M.R., Staels B., Vidal H., and Auwerx J. The organization, promoter analysis, and expression of the human PPARgamma gene. J. Biol. Chem. 272 (1997) 30
3. Werman A., Hollenberg A., Solanes G., Bjorbaek C., Vidal-Puig A.J., and Flier J.S. Ligand-independent activation domain in the N terminus of peroxisome proliferator-activated receptor gamma (PPARgamma). Differential activity of PPARgamma1 and -2 isoforms and influence of insulin. J. Biol. Chem. 272 (1997) 32
4. Fajas L., Fruchart J.C., and Auwerx J. PPARgamma3 mRNA: a distinct PPARgamma mRNA subtype transcribed from an independent promoter. FEBS Lett. 438 (1998) 1-2
5. Leparc G.G., and Mitra R.D. Non-EST-based prediction of novel alternatively spliced cassette exons with cell signaling function in Caenorhabditis elegans and human. Nucl. Acids Res. 35 (2007) 10
6. Vidal-Puig A.J., Considine R.V., Jimenez-Linan M., Werman A., Pories W.J., Caro J.F., and Flier J.S. Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids. J. Clin. Invest. 99 (1997) 10
7. Tontonoz P., Hu E., and Spiegelman B.M. Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor. Cell 79 (1994) 7
8. Mukherjee R., Jow L., Croston G.E., and Paterniti Jr. J.R. Identification, characterization, and tissue distribution of human peroxisome proliferator-activated receptor (PPAR) isoforms PPARgamma2 versus PPARgamma1 and activation with retinoid X receptor agonists and antagonists. J. Biol. Chem. 272 (1997) 12
9. Jackson S.M., and Demer L.L. Peroxisome proliferator-activated receptor activators modulate the osteoblastic maturation of MC3T3-E1 preosteoblasts. FEBS Lett. 471 (2000) 1
10. Jeon M.J., Kim J.A., Kwon S.H., Kim S.W., Park K.S., Park S.W., Kim S.Y., and Shin C.S. Activation of peroxisome proliferator-activated receptor-gamma inhibits the Runx2-mediated transcription of osteocalcin in osteoblasts. J. Biol. Chem. 278 (2003) 26
11. Chiba H., Sawada N., Ono T., Ishii S., and Mori M. Establishment and characterization of a simian virus 40-immortalized osteoblastic cell line from normal human bone. Jpn. J. Cancer Res. 84 (1993) 3
12. Eijken M., Swagemakers S., Koedam M., Steenbergen C., Derkx P., Uitterlinden A.G., van der Spek P.J., Visser J.A., de Jong F.H., Pols H.A., and van Leeuwen J.P. The activin A-follistatin system: potent regulator of human extracellular matrix mineralization. FASEB J. 21 (2007) 11
13. Eijken M., Hewison M., Cooper M.S., de Jong F.H., Chiba H., Stewart P.M., Uitterlinden A.G., Pols H.A., and van Leeuwen J.P. 11beta-Hydroxysteroid dehydrogenase expression and glucocorticoid synthesis are directed by a molecular switch during osteoblast differentiation. Mol. Endocrinol. 19 (2005) 3
14. Mandard S., Zandbergen F., Tan N.S., Escher P., Patsouris D., Koenig W., Kleemann R., Bakker A., Veenman F., Wahli W., Muller M., and Kersten S. The direct peroxisome proliferator-activated receptor target fasting-induced adipose factor (FIAF/PGAR/ANGPTL4) is present in blood plasma as a truncated protein that is increased by fenofibrate treatment. J. Biol. Chem. 279 (2004) 33
15. Targett-Adams P., McElwee M.J., Ehrenborg E., Gustafsson M.C., Palmer C.N., and McLauchlan J. A PPAR response element regulates transcription of the gene for human adipose differentiation-related protein. Biochim. Biophys. Acta 1728 (2005) 1-2
16. Desvergne B., Michalik L., and Wahli W. Be fit or be sick: peroxisome proliferator-activated receptors are down the road. Mol. Endocrinol. 18 (2004) 6
17. Stains J.P., and Civitelli R. Genomic approaches to identifying transcriptional regulators of osteoblast differentiation. Genome Biol. 4 (2003) 7
18. Eijken M., Koedam M., van Driel M., Buurman C.J., Pols H.A., and van Leeuwen J.P. The essential role of glucocorticoids for proper human osteoblast differentiation and matrix mineralization. Mol. Cell Endocrinol. 248 (2006) 1-2